Accumulating data on the biological roles of BACE1, particularly evidence that completes inhibition of BACE1 activity which is deleterious for normal neuronal function, suggests caution for using BACE1 inhibitors as a treatment for AD. This evidence concerns the gene BACE1 and Alzheimer disease.